Anthrax Vaccine Adverse Reactions: Hearing Before the Subcommittee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, First Session, July 21, 1999

Couverture

À l'intérieur du livre

Pages sélectionnées

Autres éditions - Tout afficher

Expressions et termes fréquents

Fréquemment cités

Page 119 - With the exception of injection site reactions, all of the adverse events noted above occur in the absence of immunization. While the data gathered from the VAERS system can serve as a useful tool in identifying potential problems, the reports on anthrax vaccine received thus far do not raise any specific concerns about the safety of the vaccine.
Page 91 - This concludes my formal statement If you or other members of the Subcommittee have any questions, we will be pleased to respond to them.
Page 123 - VAERS data are available to the public through the National Technical Information Service and also through requests to FDA's Freedom of Information office.
Page 33 - And whereas all officers, civil and military, are bound by oath that they will support and defend the Constitution against all enemies, foreign and domestic, and will bear true faith and allegiance to the same ; And whereas all officers of the army and navy of the United States, in accepting their commissions under the laws of Congress and the rules and articles of war...
Page 77 - United States General Accounting Office Testimony Before the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, House of Representatives...
Page 104 - ... Agency convened a team of civilian and military medical experts to design a set of studies to assess the long-term safety of the anthrax vaccine, in response to requests from Service Members, their families and recommendations of the General Accounting Office. In designing these studies, we have drawn from the accumulated experience of some of the nation's best vaccine researchers at CDC and FDA. A new long term study is also underway to determine whether individuals who received multiple vaccines,...
Page 106 - Policy for Reporting Adverse Reactions Associated with the Anthrax Vaccine Immunization Program (AVIP)" created 30 Jun 98, issued 21 Apr 99 for Service coordination/implementation outlines clinical protocols and algorithms for submitting VAERS. This policy also requires submission of an "Anthrax Vaccine Adverse Reaction Supplemental Form
Page 70 - Caldera authorized indemnification of the manufacturer stating: "the obligation assumed by MRPl under this contract involves unusually hazardous risks associated with the potential for adverse reactions in some recipients and the possibility that the desired immunological effect will not be obtained by all recipients.
Page 110 - An Anthrax Vaccine Immunization Program Videotape explaining the threat, safety, efficacy of the vaccine. The video features prominent civilian and Government scientists and vaccine experts explaining and endorsing the vaccine. • DOD is currently collaborating with CDC to array this information in the format of Vaccine Information Statements (VIS) that civilian health care providers around the country give America's children, adolescents, and adults during routine vaccinations. • Clinical Guidelines...
Page 118 - Center for Biologies, Evaluation and Research at The Food and Drug Administration...

Informations bibliographiques